| Co-expression of cancer stem cell markers OCT4 and NANOG predicts poor prognosis in renal cell carcinomas A Rasti, M Mehrazma, Z Madjd, M Abolhasani, L Saeednejad Zanjani, ... Scientific reports 8 (1), 11739, 2018 | 97 | 2018 |
| ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder H Keymoosi, E Gheytanchi, M Asgari, A Shariftabrizi, Z Madjd Asian Pacific Journal of Cancer Prevention 15 (5), 2013-2020, 2014 | 78 | 2014 |
| MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches SH Aghaee-Bakhtiari, E Arefian, M Naderi, F Noorbakhsh, V Nodouzi, ... Tumor Biology 36, 4203-4212, 2015 | 54 | 2015 |
| Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis M Mohsenzadegan, Z Madjd, M Asgari, M Abolhasani, M Shekarabi, ... Cancer Immunology, Immunotherapy 62, 1609-1618, 2013 | 53 | 2013 |
| Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma A Rasti, M Abolhasani, LS Zanjani, M Asgari, M Mehrazma, Z Madjd Journal of cancer research and clinical oncology 143, 95-104, 2017 | 50 | 2017 |
| Renal biopsy findings in Iran: case series report from a referral kidney center S Ossareh, M Asgari, E Abdi, H Nejad-Gashti, Y Ataipour, S Aris, ... International urology and nephrology 42, 1031-1040, 2010 | 50 | 2010 |
| Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men M Ghafoori, P Varedi, SJ Hosseini, M Asgari, M Shakiba Urology journal 6 (3), 182-188, 2009 | 50 | 2009 |
| Co-expression of putative cancer stem cell markers CD44 and CD133 in prostate carcinomas E Kalantari, M Asgari, S Nikpanah, N Salarieh, MH Asadi Lari, Z Madjd Pathology & Oncology Research 23, 793-802, 2017 | 49 | 2017 |
| Increased expression of ALDH1A1 in prostate cancer is correlated with tumor aggressiveness: a tissue microarray study of Iranian patients E Kalantari, FH Saadi, M Asgari, A Shariftabrizi, R Roudi, Z Madjd Applied immunohistochemistry & molecular morphology 25 (8), 592-598, 2017 | 48 | 2017 |
| Expression of cancer stem cell markers OCT4 and CD133 in transitional cell carcinomas S Sedaghat, E Gheytanchi, M Asgari, R Roudi, H Keymoosi, Z Madjd Applied Immunohistochemistry & Molecular Morphology 25 (3), 196-202, 2017 | 46 | 2017 |
| High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma R Ghods, MH Ghahremani, Z Madjd, M Asgari, M Abolhasani, S Tavasoli, ... Cancer Immunology, Immunotherapy 63, 1319-1327, 2014 | 44 | 2014 |
| Estrogen receptor beta expression in prostate adenocarcinoma M Asgari, A Morakabati Diagnostic pathology 6, 1-4, 2011 | 41 | 2011 |
| Interleukin-12 and Interleukin-6 Gene Polymorphisms and Risk of Bladder Cancer in the Iranian Population Nader, M Jahed, M Mivehchi, T Majidizadeh, M Asgary, SA Hosseini Asian Pacific Journal of Cancer Prevention 15 (18), 7869-7873, 2014 | 35 | 2014 |
| Downregulation of miR‑1266‑5P, miR‑185‑5P and miR‑30c‑2 in prostatic cancer tissue and cell lines S Ostadrahimi, S Fayaz, M Parvizhamidi, M Abedi‑Valugerdi, M Hassan, ... Oncology letters 15 (5), 8157-8164, 2018 | 34 | 2018 |
| Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma LS Zanjani, Z Madjd, M Abolhasani, A Rasti, O Fodstad, Y Andersson, ... Biomarkers in Medicine 12 (1), 45-61, 2018 | 34 | 2018 |
| Expression of prostate stem cell antigen (PSCA) in prostate cancer: a tissue microarray study of Iranian patients J Taeb, M Asgari, M Abolhasani, MM Farajollahi, Z Madjd Pathology-Research and Practice 210 (1), 18-23, 2014 | 34 | 2014 |
| Tropisetron Ameliorates Early Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats. SM Barzegar-Fallah A, Alimoradi H, Asadi F, Dehpour AR, Asgari M Clin Exp Pharmacol Physiol, 2015 | 32 | 2015 |
| Study of NGEP expression pattern in cancerous tissues provides novel insights into prognostic marker in prostate cancer M Mohsenzadegan, M Shekarabi, Z Madjd, M Asgari, M Abolhasani, ... Biomarkers in medicine 9 (4), 391-401, 2015 | 30 | 2015 |
| Renal malakoplakia presenting as a renal mass in a 55-year-old man: a case report M Abolhasani, AM Jafari, M Asgari, H Salimi Journal of Medical Case Reports 6, 1-4, 2012 | 30 | 2012 |
| Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer E Kalantari, T Taheri, S Fata, M Abolhasani, M Mehrazma, Z Madjd, ... World Journal of Surgical Oncology 20 (1), 15, 2022 | 27 | 2022 |
Maryam AbolhasaniAssociate Professor of Pathology, Iran University of Medical Sciences在 iums.ac.ir 的电子邮件经过验证
